The effect of beta-blocking agents on morbidity und mortality following coronary artery bypass surgery; [Kronik beta bloker kullaniminin koroner baypas cerrahisi sonrasi morbidite ve mortalite üzerine etkileri]

Simple item page
dc.contributor.authorÖztürk T.
dc.contributor.authorKoçan A.A.
dc.contributor.authorYildirim F.
dc.contributor.authorAlp D.
dc.contributor.authorKurdal T.
dc.date.accessioned2024-07-22T08:18:26Z
dc.date.available2024-07-22T08:18:26Z
dc.date.issued2013
dc.description.abstractObjective: Aim of this study was to investigate the effect of beta-blocking agents on both short and long-term morbidity and mortality in patients undergoing coronary artery bypass surgery. Material and Methods: Between January 2010 and March 2012, the patients undergoing coronary artery bypass surgery in our cardiovascular surgery clinic were divided into two groups; Group B included the patients who had (Group B) or had not (Group C) been using beta-blocking agents preoperatively, Demographic and clinical characteristics, intraoperative and postoperative clinical parameters as well as short (30-days) and long-term (1 year) rates of morbidity and mortality were retrospectively evaluated. Results: Number of patients with atrial fibrillation was significantly lower in Group B (n=17, 20% vs. n=28, 35%; p<0.01). Frequency of agitation-delirium in Group B was also significantly less than Group C (n=2, 3% vs. n=8, 10%; p=0.05). Thirty-day morbidity was also higher in Group C than Group B (n=28, 35% vs. n=17, 20%; p<0.04), however this difference disappeared after 1 year (n=30 38% vs. n=24, 28%; p=0.2). Neither 30-day nor 1 year-mortality rates were statistically significant between Groups B and C (p=0.4 and p=0.2, respectively). Conclusion: Compared to the control group, the frequencies of both atrial fibrillation and agitation-delirium were significantly lower in Group B in this cohort of patients. The long term use of beta-blocking agents prior to coronary artery bypass surgery appears to markedly reduce 30-day morbidity, despite this effect was not reflected on short and long-term mortality rates.
dc.identifier.DOI-ID10.5222/GKDAD.2013.080
dc.identifier.issn13055550
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17274
dc.language.isoTurkish
dc.rightsAll Open Access; Bronze Open Access
dc.subjectbeta adrenergic receptor blocking agent
dc.subjectagitation
dc.subjectarticle
dc.subjectcardiovascular mortality
dc.subjectcontrolled study
dc.subjectcoronary artery bypass surgery
dc.subjectdemography
dc.subjecthuman
dc.subjectlong term care
dc.subjectmorbidity
dc.subjectpreoperative period
dc.subjectretrospective study
dc.titleThe effect of beta-blocking agents on morbidity und mortality following coronary artery bypass surgery; [Kronik beta bloker kullaniminin koroner baypas cerrahisi sonrasi morbidite ve mortalite üzerine etkileri]
dc.typeArticle

Files

Collections

Scopus Koleksiyonu